Sales rise 50.00% to Rs 0.09 crore
Net Loss of Transgene Biotek reported to Rs 2.68 crore in the quarter ended March 2016 as against net loss of Rs 4.60 crore during the previous quarter ended March 2015. Sales rose 50.00% to Rs 0.09 crore in the quarter ended March 2016 as against Rs 0.06 crore during the previous quarter ended March 2015.For the full year,net loss reported to Rs 18.96 crore in the year ended March 2016 as against net loss of Rs 19.21 crore during the previous year ended March 2015. Sales rose 6.06% to Rs 0.35 crore in the year ended March 2016 as against Rs 0.33 crore during the previous year ended March 2015.
ParticularsQuarter EndedYear EndedMar. 2016Mar. 2015% Var.Mar. 2016Mar. 2015% Var.Sales0.090.06 50 0.350.33 6 OPM %-244.44-600.00 --282.86-518.18 - PBDT-0.22-0.36 39 -0.99-2.03 51 PBT-2.68-4.60 42 -18.96-19.21 1 NP-2.68-4.60 42 -18.96-19.21 1
Powered by Capital Market - Live News
